Nektar Therapeutics
NASDAQ: NKTR
$1.37
-$0.02 (-1.4%)
Closing Price on November 7, 2024
NKTR Articles
Here are some of the top biotech names to buy at Cowen. They presented such an extensive list that we focused on the quality large cap names and the stocks with the highest upside to their target...
Published:
The analysts at Piper Jaffray have returned from meeting with some of the top biotechs the cover, and they have gleaned some interesting morsels that could be huge as the year wears on.
Published:
Piper Jaffray analyst have a list of top biotech stock picks that could bring big gains for investors. The look for high-conviction near-term binary events and lower conviction catalysts with...
Published:
ThinkstockNektar Therapeutics (NASDAQ: NKTR) may have just burned a serious bridge for its future. The company is developing drugs for pain management and for cancer, and now its investigational drug...
Published:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen so far this Tuesday. There is a larger concentration around biotech and emerging pharma this morning, but that is...
Published:
Last Updated:
We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) is set to take...
Published:
Last Updated:
It is now getting close to the middle of May, and that means one thing for biotech investors. The king of biotech and pharma events is about to take place. The 2012 annual meeting of the American...
Published:
Last Updated:
The three major US equities indexes opened higher this morning after another (small) drop in new unemployment benefits claims and a good, but smaller-than-expected, rise in personal income and...
Published:
Last Updated:
The three major US equities indexes opened higher this morning following a better-than-expected report on US GDP growth (our coverage here) and the $712 billion purchase by eurozone banks in the...
Published:
Last Updated:
Active traders and day traders have many stocks to choose from this Monday morning. We are tracking news and moves in shares of Biostar Pharmaceuticals, inc. (NASDAQ: BSPM), Huntington Bancshares...
Published:
Last Updated:
IMS Health (RX) Bad numbers and a downgrade. Falls to $21.20 from 52-week high of $33.12. The PMI Group (PMI) Housing and mortgage markets hurt quarter. Falls to $22.80 from 52-week high of $51.46....
Published:
Last Updated:
Nektar Therapeutics (NASDAQ:NKTR) is seeing shares hitting 52-week lows after its pharmaceutical partner Pfizer Inc. (NYSE:PFE) unexpectedly said it would end its involvement in inhaled diabetes drug...
Published:
Stock Tickers: ACA, AVAV, IDIX, KERX, NKTR, REDE, STAA, TRMP, UBET, WON The DJIA & S&P 500 Index may have put in new highs today, but as you know there are always a dingy group of little...
Published:
Hovnanian (HOV) House of pain for home builders. Down to $17.36 from 52-week high of $36.66. Pulte Homes (PHM) More of the same. Drops to $23.28 from 52-week high of $35.56. Lexmark (LXK) Jury finds...
Published:
Last Updated: